Do Steroid Nasal Sprays Help Snoring? The Trials Say Less Than You'd Think
Fluticasone for snoring is advice you will find on almost every site. Two randomised placebo-controlled trials measured it against apnea severity and neither found a significant benefit. What they did find is more interesting.
"Try a steroid nasal spray" is one of the most widely repeated pieces of snoring advice in existence. The logic is clean: congestion raises nasal resistance, nasal resistance contributes to snoring, steroid sprays reduce congestion.
Two randomised placebo-controlled trials have measured whether it actually reduces disordered breathing. Neither found a significant effect on the primary outcome — and the reason that is worth knowing rather than ignoring is that it changes what you should expect the spray to do for you.
The children's trial
This is the better-powered of the two. Published in Chest in 2022, it randomised 134 children aged 5 to 12 with obstructive sleep apnea syndrome, 2:1, to three months of intranasal corticosteroids or placebo, double-blind. Children in the treatment arm were then re-randomised for a further nine months.
Median baseline obstructive apnea-hypopnea index was 5.8 events per hour. The primary outcome was OAHI change at three months, available for 122 children.
OAHI change at three months: −1.72 events per hour (IQR −3.91 to 1.92). At twelve months: −1.2 (−4.22 to 1.71). Neither differed significantly from placebo.
The authors open by noting that intranasal corticosteroids are frequently used for exactly this purpose and that their efficacy had not been rigorously tested. This was the test.
The adult trial, and its one positive finding
A 2023 randomised, double-blind, placebo-controlled trial gave fluticasone furoate 110 mcg daily or placebo for one month to adults with moderate-to-severe obstructive sleep apnea and coexisting chronic rhinitis — the group in whom you would most expect a nasal treatment to work.
It was small: 34 patients, 18 on the steroid and 16 on placebo. Entry required a BMI under 30 and a modified Mallampati score under 3, so people whose obstruction was clearly oropharyngeal were screened out.
The primary outcome, AHI, showed an adjusted mean difference of 11.5 ± 7.9 events per hour, 95% CI −4.9 to 27.8, P=0.16. Not significant, and with 34 patients that confidence interval is wide enough to hide a substantial effect.
But there was one result that did reach significance: a reduction in non-supine respiratory disturbance index (95% CI 18.9 to 93.2, P=0.01). In other words, when these patients were not lying on their backs, their breathing improved measurably.
That is a plausible finding rather than a fluke. A steroid spray works on the nose. When you are off your back, the nose is a larger share of the total resistance; when you are supine, gravity-driven collapse of the palate and tongue dominates and no amount of nasal patency compensates. The drug helps in the position where its mechanism is the bottleneck.
What this means you should expect
Steroid nasal sprays are a good treatment for rhinitis. That is what they are for and they work. Nothing here argues against using one for congestion, and if you have been prescribed one for allergic rhinitis you should keep taking it — that is a separate condition being treated on its own merits.
What the evidence does not support is expecting it to reduce your apnea severity. Two trials, one in children with reasonable numbers and one in the most favourable adult subgroup imaginable, and neither moved the primary outcome.
Evidence tier 1 that intranasal corticosteroids treat rhinitis. Tier 3 for snoring and apnea specifically — widely recommended, tested twice, not supported on the primary endpoint.
The honest framing: if your nose is blocked and you treat it, you will breathe more comfortably and may well feel you sleep better. Whether the noise your partner hears gets quieter is a different question, and whether your airway stops closing is a different question again.
Where a spray still earns its place
If your snoring is genuinely nasal and positional. The non-supine finding suggests side sleepers with nasal obstruction are the subgroup with a mechanism to exploit. Pairing nasal treatment with staying off your back is more defensible than either alone. How positional work is done properly.
If it improves CPAP tolerance. This has been examined separately — nasal steroids have been studied for their effect on CPAP compliance, and a patent nose is genuinely easier to run pressure through. A spray that keeps you on your machine is doing more for your apnea than a spray that slightly lowers your AHI would.
If the obstruction is inflammatory rather than structural. A spray addresses swollen turbinates and allergic mucosa. It does nothing for a deviated septum, nasal polyps, or a collapsing nasal valve, and months of spray for a structural problem is months lost. Where your airway actually narrows, and why one nostril blocks at a time.
What to do instead, if the goal is less snoring
Treat the nose because a blocked nose is worth treating — with saline irrigation alongside the spray, which has its own modest evidence and no downside. Nasal irrigation for snoring.
Then work out where your airway is actually narrowing rather than assuming it is the nose, because that assumption is why so many people cycle through sprays, strips and dilators without improvement. If the cheek-pull test does nothing for you, the nasal valve is not your problem. Nasal strips versus nasal spray, compared directly.
And no nasal spray treats obstructive sleep apnea. The children's trial measured apnea directly and found no benefit. If you have witnessed breathing pauses, gasping arousals, unrefreshing sleep, or daytime sleepiness that more sleep does not fix, a spray is not the answer and a diagnosis is. Snoring versus apnea.